IVF chains in India turn to AI to cut costs and boost success rates

Indian fertility chains are adopting artificial intelligence (AI) to improve success rates and affordability in in-vitro fertilisation (IVF).

- Aneek Chatterjee Bengaluru, 12 September

Operators like Nova IVF, Birla Fertility, Prime IVF, Ferty9 and Motherhood IVF are deploying AI-driven tools for embryo and sperm selection to boost accuracy, reduce costs and expand access nationwide.

Bengaluru-based Nova IVF Fertility recently introduced Vita Embryo, an AI-driven embryo assessment tool developed in partnership with South Korea's Kai Health.

"We strongly believe that the IVF lab is at the heart of every fertility treatment and continuously look at how we can adopt medical and technological innovations in the lab," said Chief Executive Officer (CEO) Shobhit Agarwal.

Citing global studies, Agarwal said Vita Embryo showed 12 per cent higher precision, improved embryo ranking and better pregnancy outcomes.

While adoption costs are significant, Nova—backed by Asia Healthcare Holdings—is not charging patients extra and aims to expand AI-enabled services across Tier-I and -II cities.

Balancing cost and efficiency
The upfront cost of integrating AI is high, driven by licensing, infrastructure and training. But experts argue the investment pays for itself.